Medellada, John Mike .

HRN: 24-58-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2024
CEFUROXIME 750MG (VIAL)
02/19/2024
02/26/2024
IV
410mg
Q8
UTI; Amoebiasis
Waiting Final Action 
02/19/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/19/2024
02/26/2024
ORAL
5ml
Q8
Amoebiasis
Waiting Final Action 
02/20/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/20/2024
02/27/2024
ORAL
6ml
Q8
Age
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: